Skip to ContentGo to accessibility page

Key Terms

acute myocardial infarction (AMI)
death of cardiac tissue due to lack of oxygen
adrenergic agonist
a drug that stimulates adrenergic receptors, resulting in sympathetic nervous system stimulation
anaphylaxis
systemic and overwhelming immune response to an antigen
angina
discomfort in the front of the chest, neck, shoulders, jaw, or arms that is precipitated by physical exertion and is relieved by rest or sublingual nitrates
anticholinergic
having the effect of inhibiting the cholinergic receptors, which then inhibits the parasympathetic nervous system
asystole
a state of cardiac standstill; complete cessation of electrical activity of the heart
atrial fibrillation with rapid ventricular response
a dysrhythmia that involves rapid electrical stimulation, causing the atria and ventricles to contract rapidly
calcium channel blocker
a classification of drugs that prevent calcium from entering cells by binding to long-acting voltage-gated calcium channels in the heart, smooth muscle, and pancreas
cardiac output
the product of the heart rate and stroke volume, or the amount of blood ejected with each heartbeat
cardiogenic shock
shock caused by cardiac damage (pump failure)
defibrillation
administration of electrical shock to a person experiencing a life-threatening cardiac dysrhythmia in an effort to restore normal sinus rhythm
dysrhythmia
an irregular heart rhythm
hypovolemic shock
decreased tissue perfusion caused by decreased circulating blood volume
infarction
cell death due to lack of oxygen
inotropic agent
a drug that causes the heart to contract with more force
ischemia
deficient supply of blood to tissues, which can cause injury
nitrate
a classification of drugs that cause vasodilation of blood vessels by imparting nitric oxide, which relaxes smooth muscles
opioid agonist
a drug that stimulates the opioid receptors and decreases pain sensations
oxygen saturation
measure of how much hemoglobin is bound to oxygen in the bloodstream
pulmonary edema
excessive fluid in the lungs
pulseless electrical activity
a life-threatening dysrhythmia in which the electrical system conducts impulses but the cardiac myocytes do not respond
pulseless ventricular tachycardia
a life-threatening dysrhythmia in which the ventricles contract so rapidly that a pulse cannot be detected
shock
decreased tissue perfusion to the point of hypoxia, which causes cells to undergo anaerobic metabolism; if not reversed, will lead to cell and tissue death
supraventricular tachycardia
rapid heart rate that originates above the ventricles
symptomatic bradycardia
heart rate less than 60 beats/min that causes the individual to have symptoms such as dizziness, lightheadedness, or fainting
systemic vascular resistance
resistance to blood flow by the blood vessels
ventricular fibrillation
a life-threatening dysrhythmia originating in the ventricles in which the ventricles are not coordinated in their contraction, leading to minimal cardiac output
ventricular tachycardia
a dysrhythmia that originates from the ventricles and causes them to contract rapidly
Citation/Attribution
Reuse and redistribution of this content in digital or print format:
  • This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's prior written permission.
  • This book uses the Creative Commons Attribution-NonCommercial-ShareAlike License, which means that you can reuse and modify the material only for noncommercial purposes, must attribute OpenStax, and must distribute any derivative works under the same license.
  • Any commercial printing of this textbook, including using a local or custom printer, must be approved by OpenStax, and proper citation provided.
  • OpenStax-copyrighted images, activities, assessments, and similar components of this book are subject to the same licensing – CC-BY-NC-SA. They can be used for noncommercial purposes with attribution. Commercial use requires permission.
  • Permission requests: Anyone who intends to incorporate this content (including text, images, and other components) into large language models, use it in AI offerings, use it commercially (including in print), and/or has questions about another use case is welcome to complete our reuse request form.
Attribution information
  • If you are redistributing all or part of this book in a noncommercial print format, then you must include on every physical page the following attribution:

    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction

  • If you are redistributing all or part of this book in a noncommercial digital format, then for every page that includes OpenStax content, you must license the derivative work under the same CC-BY-NC-SA license as the original, and include on every digital page view the following attribution:

    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction

Citation information

The information below includes the information needed to generate citations in most major styles (APA, MLA, etc.); you must reformat and organize the information as needed to fit the requirements of the style. Use the information below to generate a citation. We recommend using a citation tool such as this one.

© Apr 23, 2026 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo, and Rice University name, and Rice University logo trademarks, or wordmarks are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.